Stem Cells Market By Product (Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells, Very Small Embryonic Like Stem Cells), By Application (Regenerative Medicine, Drug Discovery And Development), By Therapy (Autologous Stem Cell Therapy, Allogeneic Stem Cell Therapy) - Growth, Future Prospects, And Competitive Analysis, 2017 - 2025

Global Stem Cells Market by Products (Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells and Very Small Embryonic Like Stem Cells) by Applications (Regenerative Medicine, Drug Discovery and Development) by Therapy (Autologous Stem Cells Therapy, Allogenic Stem Cells Therapy) - Market Growth, Future Prospects & Competitive Analysis, 2017 – 2025

To accelerate stem cell technology in perspective of drug discovery and development the pharmaceutical giants are currently focusing on integrating differentiation pathway discovery in non-human and human systems, stem cells training courses and institutional core facilities and developing stem cells gene tagged libraries. Additionally optimization of the cellular models and designs of stem cells employed are taking place with special focus on euploid, developmentally manipulative human models, probe mechanistic and phenotypic robustness of the natural genetic variation.

For the purpose of this study, the various products studied includes adult stem cells, human embryonic stem cells, induced pluripotent stem cells, very small embryonic like stem cells. Adult stem cells are further classified as (neuronal stem cells, hematopoietic stem cells, mesenchymal stem cells, umbilical cord stem cells and others). The applications are classified as regenerative medicines and drug discovery and development. Regenerative medicines are further categorized as (neurology, orthopedics, oncology, hematology, cardiovascular diseases, diabetes, liver disorders and others). Therapy segment is further categorized as autologous stem cells therapy and allogenic stem cells therapy. Market size estimates and forecast of these segments for the period 2015 to 2025 are provided in terms of US$ Mn along with the respective CAGRs for the period 2017 to 2025, considering 2016 as the base year.

The geographic segmentation of the global stem cells market is performed for the regions North America, Europe, Asia Pacific, Latin America and Middle East and Africa markets. The regions are also further sub-segmented on the basis of major countries:

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • France
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Rest of Asia Pacific
• Latin America
  • Mexico
  • Brazil
  • Rest of LATAM
• Middle East and Africa
  • GCC
  • Rest of Middle East and Africa

Market size estimates and forecast for these segments for the period 2015 to 2025 are provided in terms of US$ Mn along with the respective CAGRs for the period 2017 to 2025, considering 2016 as the base year.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints and opportunities) to have a good understanding of the current and anticipated trends in the global stem cells market. Market attractiveness assessment and competitive landscape analysis by key players are also presented in the study. Furthermore, this report concludes with profiling of key market players currently enjoying prominent position in the global stem cells market. The key players profiled in this report are Advanced Cell Technology, Inc., BIOTIME, Inc., BrainStorm Cell Therapeutics, Caladrius, Cellartis AB, Celgene Corporation, CellGenix GmbH, Gamida Cell, Genea BioCells, Lonza, PromoCell GmbH, Pluristem, TiGenix and Waisman Biomanufacturing.

Based on therapy, the global stem cells market is categorized into:

• Autologous Stem Cells Therapy
• Allogenic Stem Cells Therapy

In 2016, the autologous stem cell therapy segment held the largest market share chiefly due to factors such as high body compatibility, no immunological rejection. Additionally it can take place outside the operating room without giving anesthesia. The limitation of the autologous stem cell therapy are that the patient needs to be in close proximity of the hospital or research center, it is a non-scalable technique and enrolls only small patient population. Allogenic stem cell therapy will be the fastest growing market throughout the forecast period 2017-2025 majorly due to its application in oncology as it gives the graft versus cancer effect in which the donor cells make their own immune cells which helps in destroying any cancer cells remaining after high dose treatment. Additionally the donor could be asked to donate more stem cells and white blood cells whenever required. The limitation of this therapy is the graft versus host disease where the donor immune cells attacks the host healthy cells and the risk of infection even though the donors are tested before, as the infections surface after the allogenic transplant as the host immune system is suppressed due to immunosuppressive drugs.

For the purpose of this study, the global stem cells market is categorized into the following regional and country specific markets:

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • France
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East and Africa
  • GCC
  • Rest of Middle East and Africa

North America was observed to be the largest market for stem cells in the base year 2016. The dominance of North America is mainly attributed to the rising prevalence of chronic diseases, enhanced government spending in the research and development facilities in healthcare institutions and affordable reimbursement scenario. The market growth in Europe is mainly attributed to the rising demand for epigenetics and its application in biomedical science. Increasing popularity of personalized medication and large number of clinical trials conducted on therapeutic application of stem cells in treating hematological disorders. Asia Pacific was observed as the fastest growing regional segment throughout the forecast period 2017-2025. Factors that are anticipated to propel the market growth are presence of geriatric population suffering with chronic diseases requiring immediate medical intervention, technological advancement in the extraction and harvesting of stem cells for therapeutic applications and supportive regulatory environment for stem cells products. Moreover, factors such as developing health infrastructure, untapped market in remote areas with unmet medical needs are going to fuel the rapid growth of stem cells market in Latin America, and Middle East and Africa in the near future.